U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H27NO9
Molecular Weight 497.4939
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IDARUBICIN

SMILES

[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]2C[C@@](O)(CC3=C(O)C4=C(C(=O)C5=C(C=CC=C5)C4=O)C(O)=C23)C(C)=O

InChI

InChIKey=XDXDZDZNSLXDNA-TZNDIEGXSA-N
InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1

HIDE SMILES / InChI
Molecular Formula C26H27NO9
Molecular Weight 497.4939
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
123738
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:35:27 UTC 2023
Edited
by admin
on Sat Dec 16 17:35:27 UTC 2023
Record UNII
ZRP63D75JW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IDARUBICIN
INN   MI   VANDF   WHO-DD  
INN  
Official Name English
Idarubicin [WHO-DD]
Common Name English
IDARUBICIN [MI]
Common Name English
idarubicin [INN]
Common Name English
ZAVEDOS
Brand Name English
5,12-NAPHTHACENEDIONE, 9-ACETYL-7-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,9,11-TRIHYDROXY-, (7S,9S)-
Common Name English
IDARUBICIN [VANDF]
Common Name English
(1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE
Common Name English
IDARUBICINE
Common Name English
Classification Tree Code System Code
WHO-ATC L01DB06
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
NDF-RT N0000175414
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
LIVERTOX 496
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
NDF-RT N0000007530
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
NDF-RT N0000007530
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
FDA ORPHAN DRUG 70892
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
FDA ORPHAN DRUG 70992
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
WHO-VATC QL01DB06
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
NCI_THESAURUS C1594
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
NDF-RT N0000000176
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
NDF-RT N0000007530
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
Code System Code Type Description
SMS_ID
100000083694
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
EPA CompTox
DTXSID7023142
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
CAS
58957-92-9
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
ChEMBL
CHEMBL1117
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
DRUG BANK
DB01177
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
NCI_THESAURUS
C562
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
MERCK INDEX
m6197
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY Merck Index
WIKIPEDIA
IDARUBICIN
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
DRUG CENTRAL
1414
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
EVMPD
SUB08111MIG
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
DAILYMED
ZRP63D75JW
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
FDA UNII
ZRP63D75JW
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
RXCUI
5650
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY RxNorm
IUPHAR
7083
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
PUBCHEM
42890
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
MESH
D015255
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
INN
5174
Created by admin on Sat Dec 16 17:35:28 UTC 2023 , Edited by admin on Sat Dec 16 17:35:28 UTC 2023
PRIMARY
Related Record Type Details
MRP-1
TRANSPORTER -> SUBSTRATE
Structure of LADIRUBICIN
DERIVATIVE -> PARENT
Structure of IDARUBICIN HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of IDARUBICINOL
METABOLITE ACTIVE -> PARENT
MAJOR
PLASMA
Related Record Type Details
Structure of IDARUBICIN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966